Cardiovascular Diseases
The research program at Praxis für Prävention und Therapie Prof. Dr. med. Stephan Jacob evaluates cardiovascular disease outcomes in individuals with type 2 diabetes mellitus, seeking to lower the risk of heart attacks, strokes, and related events through innovative therapies.
- Assessment of major adverse cardiac events
- Comparison of new glucose‑lowering agents with standard care
- Exploration of cardiovascular safety in high‑risk populations
The site’s focus on heart health aligns with its broader commitment to improving outcomes for patients with metabolic disorders.
Nutritional and Metabolic Diseases
Clinical investigations target chronic weight management and broader metabolic health, testing novel medications designed to produce durable weight loss and improve metabolic control.
- Evaluation of sustained body‑weight reduction
- Impact on glucose regulation and insulin sensitivity
- Safety and tolerability of long‑term metabolic therapies
Praxis für Prävention und Therapie Prof. Dr. med. Stephan Jacob leverages its expertise to advance treatment options for patients struggling with obesity and related metabolic conditions.
